Skip to main content

Search

HIV

HIV

HIV

INFECTIOUS DISEASES & VACCINES - HIV

Despite the progress made, HIV remains one of the largest global health threats of our time. We won’t stop until we have helped to make HIV history.

Science has transformed HIV from a serious, fatal illness to a manageable, chronic condition.[1] Yet many people living with HIV are still not virally suppressed. Many lack access to the treatment and resources needed for the best health outcomes. The stigma of HIV also plays a major role in the continuation of this crisis, affecting diagnosis, care and the emotional well-being of those living with the disease.[13] Access to available treatments will help those affected with HIV to live their best lives, alongside education and empowerment.

Structure of HIV

Roughly 2.3 million people are currently living with HIV in Europe, as reported in 2019.[2]
It is estimated that 1 in 5 people living with HIV do not know that they are infected.[13]

At Janssen, we are building on our 25-year commitment to make HIV history. We aim to change the course of this epidemic from our passionate pursuit of innovative treatment for the long-term suppression of HIV, to effective prevention.

Indeed, while controlling HIV is important, we also focus on improving the lives of people living with HIV. For example, our Moving Fourth initiative aims to tackle HIV-related health challenges faced by people living with HIV, such as associated emotional and physical co-morbidities, mental health issues, financial stresses and potential HIV-related stigma. Find out more about the Moving Fourth initiative in the videos below.

We are deeply committed to the millions of people living with or at-risk of acquiring HIV. We are optimistic about the future – we’ve helped to change the face of HIV in the past, and we are convinced we can change it again.

Find out more about the Moving Fourth initiative:

 

BACK TO INFECTIOUS DISEASES & VACCINES